Jefferies

Infosys Share Price Today (27 November 2025): Buyback Oversubscribed 8.26x as Jefferies Stays Bullish on INFY

Infosys Limited (NSE: INFY, BSE: 500209, NYSE: INFY) spent Thursday, 27 November 2025, in the spotlight as final numbers for its ₹18,000‑crore share buyback landed — and they were huge. The tender offer has drawn bids more than eight times

27 November 2025

Visa Inc (V) Stock Today, November 26, 2025: Stablecoin Bet, Jefferies Buy Call and Big-Money Flows

Visa Inc (NYSE: V) spent Wednesday trading around $335 per share, as investors digested a new stablecoin settlement partnership with Aquanow, a reaffirmed Buy rating and $410 price target from Jefferies, and a flurry of institutional and political buying disclosures.

26 November 2025

Blue Chip Stocks · Cryptocurrencies · Financial News · Investment Strategies · NYSE:V · Stock Market

Spotify (SPOT) Stock on November 24, 2025: Jefferies’ $800 Target, Audiobook Push and New Institutional Buying

Spotify Technology S.A. (NYSE: SPOT) is trading lower today after a volatile week, even as Wall Street analysts reiterate bullish ratings, hedge funds add to positions, and the company doubles down on high‑margin initiatives like audiobooks and premium tiering. By

24 November 2025

Financial Analysis · Investment Strategies · Spotify News · Stock Market · Technology Stocks

GSK (GSK) news today — Nov 11, 2025: New AN2 TB collaboration, buyback activity filed, shares test 12‑month high

GSK Share Price Today, 20 November 2025: LON:GSK Edges Higher as Jefferies Lifts Target and Oncology Deal Builds Momentum

London, 20 November 2025 — GSK plc (LON:GSK, NYSE:GSK) finished Thursday’s session slightly higher, as upbeat broker commentary and a string of recent R&D announcements helped support the pharma giant’s share price against a volatile FTSE 100 backdrop. Key takeaways

20 November 2025

Analyst Ratings · Oncology · Pharma News · Share Prices · Stock Market

Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle Stock Today (Nov 17, 2025): ORCL Slips as Credit Hedges Rise; Jefferies Reaffirms $400 Target and 80% Upside

Published: November 17, 2025 Key takeaways What moved Oracle stock today Jefferies sticks with $400 target, sees selloff as overdone.In a note published this morning, Jefferies’ Brent Thill reaffirmed a $400 target on Oracle, framing the recent drawdown as an

17 November 2025

Financial Trends · Investment Analysis · NYSE:ORCL · Oracle News · Price Targets · Stock Market

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) Stock Today, November 12, 2025: Shares Nudge Higher as Jefferies Webcast Set, Metsera Deal Stays in Focus

Updated November 12, 2025 Pfizer’s stock is modestly higher in Wednesday trading. Around 2:00 p.m. ET, PFE changed hands near $25.94, up about 1.7% on the day. Earlier prints showed an intraday range of $25.25–$25.95 versus Tuesday’s close at $25.51.

12 November 2025

Financial Analysis · Investment · NYSE:PFE · Pfizer News · Pharmaceuticals · Stock Market

Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Stock Hits Multi-Month Low Amid Legal Fallout Jefferies shares have been on a wild ride in recent weeks, culminating in a steep plunge on October 16. The stock sank intraday to about $50 – territory not seen in over four

17 October 2025

Bankruptcy · Financial News · Investment Analysis · Market Trends · NYSE:JEF · Stock Market

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Financial Group’s logo displayed on the trading floor of the New York Stock Exchange. The stock has seesawed amid strong earnings and fallout from a client’s bankruptcy. reuters.com tradingview.com Earnings Soar on Dealmaking Rebound Jefferies’ latest quarterly report showcased

16 October 2025

Analyst Insights · Earnings Reports · Financial News · Investment Strategies · NYSE:JEF · Stock Market